Pacific Clinical Research

Mumbai, India Founded: 2009 • Age: 17 yrs Acquired By Chiltern International
Clinical trial management services are provided across Asian markets.

About Pacific Clinical Research

Pacific Clinical Research is a Healthcare company based in Mumbai (India) founded in 2009, and was acquired by Chiltern International in September 2014. Clinical trial management services are provided across Asian markets. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

Pacific CRO offered clinical trial management services from project management to medical writing. They catered to a wide variety of therapeutic areas including oncology, infectious diseases, metabolic diseases and CNS. The company has an Asian focus and had operations in China, Hong Kong, Korea, Malaysia, the Philippines, Singapore, Taiwan, and Thailand. Pacific Clinical Research was acquired by Chiltern International in September 2014.

Key Metrics

Investors in Pacific Clinical Research

Pacific Clinical Research has secured backing from 1 investor. Prominent investors backing the company include Chiltern International.

All
InvestorDescriptionFounded YearDomainLocation
Full service CRO with expertise in oncology related development services
1982chiltern.comBerkshire County, United States
Premium access

Investor details for Pacific Clinical Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pacific Clinical Research

2 dated milestones of Pacific Clinical Research across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pacific Clinical Research is founded.
  2. Exit Acquired by Chiltern International.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Pacific Clinical Research (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pacific Clinical Research

Pacific Clinical Research was founded in 2009.

Pacific Clinical Research is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Pacific CRO offered clinical trial management services from project management to medical writing. They catered to a wide variety of therapeutic areas including oncology, infectious diseases, metabolic diseases and CNS. The company has an Asian focus and had operations in China, Hong Kong, Korea, Malaysia, the Philippines, Singapore, Taiwan, and Thailand. Pacific Clinical Research was acquired by Chiltern International in September 2014.

Pacific Clinical Research has 1 investor. Key investors include Chiltern International.

Yes. Pacific Clinical Research was acquired by Chiltern International in September 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available